RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $387,306 | -33.0% | 46,053 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $578,426 | -21.3% | 46,053 | +3.2% | 0.00% | -20.0% |
| Q1 2023 | $735,122 | +10.2% | 44,634 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $666,832 | -27.0% | 44,634 | +9.4% | 0.01% | -37.5% |
| Q3 2022 | $913,076 | +43.6% | 40,817 | +7.5% | 0.01% | +60.0% |
| Q2 2022 | $635,864 | -44.0% | 37,962 | 0.0% | 0.01% | -37.5% |
| Q1 2022 | $1,136,203 | +51.5% | 37,962 | +55.4% | 0.01% | +33.3% |
| Q4 2021 | $750,122 | +11.9% | 24,426 | +14.8% | 0.01% | 0.0% |
| Q3 2021 | $670,612 | -13.8% | 21,269 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $778,233 | +28.2% | 21,269 | +21.1% | 0.01% | +16.7% |
| Q1 2021 | $606,911 | +6.4% | 17,556 | +27.9% | 0.01% | 0.0% |
| Q4 2020 | $570,619 | -2.4% | 13,730 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $584,761 | – | 13,730 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |